PRMT5 promotes the expansion of stem cells through histone methylation and the expression of forkhead box P1 (FOXP1) and Kruppel-like Factor 4 (KLF4), thereby enabling the development of breast tumors and chemotherapy resistance [36]. The gene discussed is KLF4; the disease is breast neoplasm.